Valuation

TMOThermo Fisher Scientific

StockNYSEÉtats-UnisHealth careEU retail: available
8/10

Ratios vs sector

Medians of Health care companies in the same region (stocks and REITs).

Lower P/E, P/B, P/S and EV/EBIT mean cheaper; higher yields, returns and margins mean more for the price. Negative multiples (losses) are left out of the medians.
MetricTMOSector medianvs median
P/E35,728,8 · n=11424 % above
P/B4,73,0 · n=19657 % above
P/S5,43,7 · n=20244 % above
EV/EBIT35,224,1 · n=10346 % above
Free-cash-flow yield2,9 %2,8 % · n=187near the median
Dividend yield0,27 %0,00 % · n=215—
Return on equity13,5 %2,7 % · n=193408 % above
Return on invested capital8,7 %3,5 % · n=176146 % above
Gross margin—62,5 % · n=152—
Net debt / EBITDA3,451,19 · n=108189 % above

Value factor: 51 of 100 within the peer group. Full score breakdown →

Sector peers

The largest companies of the same sector and region.

InstrumentP/EP/BEV/EBITFree-cash-flow yieldDividend yieldSmart Score
LLYEli Lilly & Co42,633,6—1,6 %0,6 %6/10
JNJJohnson & Johnson29,17,2—3,6 %2,1 %8/10
ABBVAbbVie79,9—33,53,6 %3,0 %5/10
MRKMerck114,68,7—4,4 %2,3 %8/10
UNHUnitedHealth25,13,418,66,7 %2,3 %9/10
AMGNAmgen26,319,724,04,4 %2,3 %6/10
GILDGILEAD—16,1—6,8 %2,1 %4/10
ABTAbbott28,53,426,84,1 %3,0 %5/10
PFEPfizer38,42,0—6,6 %5,9 %1/10
DHRDanaher39,43,035,13,5 %0,7 %5/10

Fiscal-year history

From annual SEC filings; each bar is a fiscal year, labelled by the year it ended.

Filings: U.S. SEC EDGAR · ratios computed by AI-Stock Invest from public filings and end-of-day prices · latest period 27 juin 2026 · filed 31 juill. 2026